These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9640563)

  • 1. External and internal electrostatic potentials of cholinesterase models.
    Felder CE; Botti SA; Lifson S; Silman I; Sussman JL
    J Mol Graph Model; 1997 Oct; 15(5):318-27, 335-7. PubMed ID: 9640563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in active site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase.
    Saxena A; Redman AM; Jiang X; Lockridge O; Doctor BP
    Biochemistry; 1997 Dec; 36(48):14642-51. PubMed ID: 9398183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in active-site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase.
    Saxena A; Redman AM; Jiang X; Lockridge O; Doctor BP
    Chem Biol Interact; 1999 May; 119-120():61-9. PubMed ID: 10421439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homology built model of acetylcholinesterase from Drosophila melanogaster.
    Stojan J
    J Enzyme Inhib; 1999; 14(3):193-201. PubMed ID: 10445043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active-site gorge and buried water molecules in crystal structures of acetylcholinesterase from Torpedo californica.
    Koellner G; Kryger G; Millard CB; Silman I; Sussman JL; Steiner T
    J Mol Biol; 2000 Feb; 296(2):713-35. PubMed ID: 10669619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional structures of Drosophila melanogaster acetylcholinesterase and of its complexes with two potent inhibitors.
    Harel M; Kryger G; Rosenberry TL; Mallender WD; Lewis T; Fletcher RJ; Guss JM; Silman I; Sussman JL
    Protein Sci; 2000 Jun; 9(6):1063-72. PubMed ID: 10892800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion of acetylcholinesterase to butyrylcholinesterase: modeling and mutagenesis.
    Harel M; Sussman JL; Krejci E; Bon S; Chanal P; Massoulié J; Silman I
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10827-31. PubMed ID: 1438284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asp7O in the peripheral anionic site of human butyrylcholinesterase.
    Masson P; Froment MT; Bartels CF; Lockridge O
    Eur J Biochem; 1996 Jan; 235(1-2):36-48. PubMed ID: 8631355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excavations into the active-site gorge of cholinesterases.
    Soreq H; Gnatt A; Loewenstein Y; Neville LF
    Trends Biochem Sci; 1992 Sep; 17(9):353-8. PubMed ID: 1412713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three distinct domains in the cholinesterase molecule confer selectivity for acetyl- and butyrylcholinesterase inhibitors.
    Radić Z; Pickering NA; Vellom DC; Camp S; Taylor P
    Biochemistry; 1993 Nov; 32(45):12074-84. PubMed ID: 8218285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amino acid residues controlling acetylcholinesterase and butyrylcholinesterase specificity.
    Vellom DC; Radić Z; Li Y; Pickering NA; Camp S; Taylor P
    Biochemistry; 1993 Jan; 32(1):12-7. PubMed ID: 8418833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chimeric human cholinesterase. Identification of interaction sites responsible for recognition of acetyl- or butyrylcholinesterase-specific ligands.
    Loewenstein Y; Gnatt A; Neville LF; Soreq H
    J Mol Biol; 1993 Nov; 234(2):289-96. PubMed ID: 8230213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of cholinesterase inhibition by inorganic mercury.
    Frasco MF; Colletier JP; Weik M; Carvalho F; Guilhermino L; Stojan J; Fournier D
    FEBS J; 2007 Apr; 274(7):1849-61. PubMed ID: 17355286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aromatic amino-acid residues at the active and peripheral anionic sites control the binding of E2020 (Aricept) to cholinesterases.
    Saxena A; Fedorko JM; Vinayaka CR; Medhekar R; Radić Z; Taylor P; Lockridge O; Doctor BP
    Eur J Biochem; 2003 Nov; 270(22):4447-58. PubMed ID: 14622273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of an acetylcholinesterase-fasciculin complex: interaction of a three-fingered toxin from snake venom with its target.
    Harel M; Kleywegt GJ; Ravelli RB; Silman I; Sussman JL
    Structure; 1995 Dec; 3(12):1355-66. PubMed ID: 8747462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and dynamics of the active site gorge of acetylcholinesterase: synergistic use of molecular dynamics simulation and X-ray crystallography.
    Axelsen PH; Harel M; Silman I; Sussman JL
    Protein Sci; 1994 Feb; 3(2):188-97. PubMed ID: 8003956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probing gorge dimensions of cholinesterases by freeze-frame click chemistry.
    Radić Z; Manetsch R; Fournier D; Sharpless KB; Taylor P
    Chem Biol Interact; 2008 Sep; 175(1-3):161-5. PubMed ID: 18555981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid binding of a cationic active site inhibitor to wild type and mutant mouse acetylcholinesterase: Brownian dynamics simulation including diffusion in the active site gorge.
    Tara S; Elcock AH; Kirchhoff PD; Briggs JM; Radic Z; Taylor P; McCammon JA
    Biopolymers; 1998 Dec; 46(7):465-74. PubMed ID: 9838872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Leu-Arg-Glu (LRE) adhesion motif in proteins of the neuromuscular junction with special reference to proteins of the carboxylesterase/cholinesterase family.
    Johnson G; Moore SW
    Comp Biochem Physiol Part D Genomics Proteomics; 2013 Sep; 8(3):231-43. PubMed ID: 23850873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A modular treatment of molecular traffic through the active site of cholinesterase.
    Botti SA; Felder CE; Lifson S; Sussman JL; Silman I
    Biophys J; 1999 Nov; 77(5):2430-50. PubMed ID: 10545346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.